The global agriculture biotech market is envisioned to garner $214.6 billion by 2031, growing from $93.1 billion in 2021 at a CAGR of 8.8% from 2022 to 2031.
It has become relatively vital to raise agricultural yields to meet the growing population's need for food. This is now feasible thanks to biotechnology, which has improved disease and drought resistance of crops. To make plants immune to various illnesses, scientists choose certain disease-resistance genes and inject them into the DNA of the plants. As an illustration, Cornell University and the University of Hawaii collaborated to create two papaya seed variants that were immune to the papaya ringspot virus; these seeds were commercially available in 1998 following many field experiments. Crops grown in arid settings also have a great requirement for drought tolerance.
Agricultural biotechnology is still in its infancy, and it is unclear how it will affect the environment. However, studies have indicated that it could cause an increase in herbicide-resistant weeds. As was previously said, genetic engineering entails the exchange of certain genes across species. In that aspect, the technique may introduce undesirable genes into pests and plants, making it harder to get rid of them. Additionally, it might result in the creation of new microbes like bacteria and viruses by transferring genes that increase their virulence. Plants that have been genetically modified create novel compounds like proteins that might be harmful to wildlife.
Augmented reality (AR) technology generates an enhanced version of reality by adding text, audio, visuals, and multimedia to immediate and real-time surroundings. Virtual reality, on the other hand, builds a completely new world and places you inside of it. Even though they are not biotechnologies, AR and VR are examples of advancements that are going to change the way that agriculture is done. Augmented and virtual realities might advance biotechnology development by assisting sample selection, in addition to enabling farmers to visually monitor fields, assist in training new farmers, and assist in tool appraisal.
The COVID-19 pandemic brought several uncertainties leading to severe economic losses as various businesses across the world were on a standstill. The COVID-19 pandemic caused problems for the agriculture biotech sector. The movement of goods both domestically and internationally was slowed down by lockdowns and limits on people's freedom of movement. Lockdowns also made it more difficult to get staff at ports to unload ships and perform other trade processes including physical inspections, testing, and certifications. At the same time, several countries changed the regulations controlling port access, resulting in delays from port closures and requests for more paperwork and quarantine processes.
The key players profiled in this report include KWS SAAT SE & Co. KGaA, ChemChina, Bayer AG, Corteva, Nufarm, Limagrain, MITSUI & CO., LTD, Evogene Ltd., Valent BioSciences LLC., and Marrone Bio Innovations.
It has become relatively vital to raise agricultural yields to meet the growing population's need for food. This is now feasible thanks to biotechnology, which has improved disease and drought resistance of crops. To make plants immune to various illnesses, scientists choose certain disease-resistance genes and inject them into the DNA of the plants. As an illustration, Cornell University and the University of Hawaii collaborated to create two papaya seed variants that were immune to the papaya ringspot virus; these seeds were commercially available in 1998 following many field experiments. Crops grown in arid settings also have a great requirement for drought tolerance.
Agricultural biotechnology is still in its infancy, and it is unclear how it will affect the environment. However, studies have indicated that it could cause an increase in herbicide-resistant weeds. As was previously said, genetic engineering entails the exchange of certain genes across species. In that aspect, the technique may introduce undesirable genes into pests and plants, making it harder to get rid of them. Additionally, it might result in the creation of new microbes like bacteria and viruses by transferring genes that increase their virulence. Plants that have been genetically modified create novel compounds like proteins that might be harmful to wildlife.
Augmented reality (AR) technology generates an enhanced version of reality by adding text, audio, visuals, and multimedia to immediate and real-time surroundings. Virtual reality, on the other hand, builds a completely new world and places you inside of it. Even though they are not biotechnologies, AR and VR are examples of advancements that are going to change the way that agriculture is done. Augmented and virtual realities might advance biotechnology development by assisting sample selection, in addition to enabling farmers to visually monitor fields, assist in training new farmers, and assist in tool appraisal.
The COVID-19 pandemic brought several uncertainties leading to severe economic losses as various businesses across the world were on a standstill. The COVID-19 pandemic caused problems for the agriculture biotech sector. The movement of goods both domestically and internationally was slowed down by lockdowns and limits on people's freedom of movement. Lockdowns also made it more difficult to get staff at ports to unload ships and perform other trade processes including physical inspections, testing, and certifications. At the same time, several countries changed the regulations controlling port access, resulting in delays from port closures and requests for more paperwork and quarantine processes.
The key players profiled in this report include KWS SAAT SE & Co. KGaA, ChemChina, Bayer AG, Corteva, Nufarm, Limagrain, MITSUI & CO., LTD, Evogene Ltd., Valent BioSciences LLC., and Marrone Bio Innovations.
Key Benefits For Stakeholders
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the agriculture biotech market analysis from 2021 to 2031 to identify the prevailing agriculture biotech market opportunities.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the agriculture biotech market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global agriculture biotech market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Type
- Hybrid Seeds
- Transgenic Crops
- Bio-pesticides
- Bio-fertilizers
By Technology
- Genetic Engineering
- Tissue Culture
- Embryo Rescue
- Somatic Hybridization
- Molecular Diagnostics
- Vaccine
- Others
By Application
- Crop Production
- Crop Protection
- Chemical Tolerance
- Disease Resistance
- Others
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Spain
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia-Pacific
- LAMEA
- Brazil
- United Arab Emirates
- Saudi Arabia
- South Africa
- Rest of LAMEA
Key Market Players
- Bayer AG
- KWS SAAT SE & Co. KGaA
- Corteva Agriscience
- ChemChina
- Limagrain
- Marrone Bio Innovations, Inc.
- Valent BioSciences
- ADAMA
- VILMORIN & CIE
- Certis Biologicals
Table of Contents
CHAPTER 1: INTRODUCTION
CHAPTER 2: EXECUTIVE SUMMARY
CHAPTER 3: MARKET OVERVIEW
CHAPTER 4: AGRICULTURE BIOTECH MARKET, BY TYPE
CHAPTER 5: AGRICULTURE BIOTECH MARKET, BY TECHNOLOGY
CHAPTER 6: AGRICULTURE BIOTECH MARKET, BY APPLICATION
CHAPTER 7: AGRICULTURE BIOTECH MARKET, BY REGION
CHAPTER 8: COMPETITIVE LANDSCAPE
CHAPTER 9: COMPANY PROFILES
List of Tables
List of Figures
Executive Summary
According to the report titled, “Agriculture Biotech Market," the agriculture biotech market was valued at $93.10 billion in 2021, and is estimated to reach $214.6 billion by 2031, growing at a CAGR of 8.8% from 2022 to 2031.Biotechnology helps farmers in making crop production cheaper and more effortless. For instance, some crops can be modified to fight herbicides, making weed control easier and more effective. It is possible to reduce the usage of synthetic pesticides and improve pest control by breeding other crops to be resistant to plant diseases and pests. These crop production alternatives can decrease production costs while aiding nations in fulfilling food demand. Biotechnology advancements may provide consumers with nutrient-rich foods. Biotechnology is being used by researchers to lower the number of saturated fats in cooking oils, and allergens in food, and raise the amount of disease-preventing nutrients. Biotechnological advances can help with issues like halting the spread of infectious illnesses, alleviating hunger, and addressing environmental damage.
Key driving factors such as high demand from the pharmaceutical sector are driving the agriculture biotech market. Scientists are creating medications using genetically modified crops. This may result in the formation of a new plant-made pharmaceutical sector that can help to lower the costs of production using a sustainable resource. A serious public health catastrophe has arisen as a result of the COVID-19 outbreak. The pandemic put enormous pressure on scientists to create efficient diagnostics and therapies to contain the outbreak. The urgent need for SARS-CoV-2 protein antigens and antibodies was met by certain scientists involved in plant biotechnology partnering with commercial firms for the emergency manufacturing of diagnostics and therapies. This technology is known as a transient expression in plants. Transient expression in plants can be used to create low-cost vaccinations, antiviral medications, and diagnostic tests.
The North America region is anticipated to offer ample growth opportunities to the agriculture biotech market during the forecast period owing to various factors such as well-developed biotechnology research infrastructure, favorable government policies for R&D, availability of human resources and expertise, a diverse array of agroclimatic regions, crops, and a sizable genetically modified planted area. During the projected period, the U.S. is anticipated to hold the greatest market share in this area.
The market also offers growth opportunities to the key players in the market. The pharmaceutical sector is one of the most lucrative sectors for agriculture biotech market players. Techniques employed in agriculture biotech are identical to molecular biology and biotechnology, an area that enables virus detection, the development of vaccines, disease management, and treatment. The presence of the SARS-CoV-2 virus, which causes COVID-19, was detected by scientists by utilizing the loop-mediated isothermal amplification (LAMP) and reverse transcription-quantitative polymerase chain reaction (RT-qPCR) test. Employing plants as bioreactors that can be immunized and from which the vaccine could be extracted has the possibility of creating a COVID-19 vaccine, as such has been used in vaccines against rabies, Ebola, etc.
The agriculture biotech market is segmented into type, technology, application, and region. On the basis of type, the market is categorized into hybrid seeds, transgenic crops, bio-pesticides, and bio-fertilizers. On the basis of technology, it is categorized into genetic engineering, tissue culture, embryo rescue, somatic hybridization, molecular diagnostics, vaccine, and others. On the basis of application, the market is divided into crop production, crop protection, chemical tolerance, disease resistance, and others. Region wise, it is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, UK, France, Italy, and rest of Europe), Asia-Pacific (China, India, Japan, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, United Arab Emirates, Saudi Arabia, South Africa, and rest of LAMEA).
The key players profiled in the study include KWS SAAT SE & Co. KGaA, ChemChina, Bayer AG, Corteva, Nufarm, Limagrain, MITSUI & CO., LTD, Evogene Ltd., Valent BioSciences LLC., and Marrone Bio Innovations. The players in the market have been actively engaged in the adoption of various strategies such as acquisition, product launch, and expansion to remain competitive and gain an advantage over the competitors in the market. For instance, in 2022, Corteva Agriscience announced the expansion of its sunflower seed business in Europe, with the completion of an additional euro 14m of investment in the Afumati production facility in Romania.
Key Market Insights
- By type, the hybrid seeds segment was the highest revenue contributor to the agriculture biotech market in 2021. However, the bio-fertilizers segment is estimated to be the fastest growing segment during the forecast period.
- By technology, genetic engineering segment dominated the global agriculture biotech market in 2021 and vaccine segment is expected show a fastest CAGR throughout the forecast period.
- By Application, crop production segment dominated the global agriculture biotech market in 2021 and is expected to maintain its dominance throughout the forecast period.
- Based on region, Europe was the highest revenue contributor in 2021 and Asia-Pacific is expected to witness the fastest growth during the forecast period.
Companies Mentioned
- Bayer AG
- KWS SAAT SE & Co. KGaA
- Corteva Agriscience
- ChemChina
- Limagrain
- Marrone Bio Innovations, Inc.
- Valent BioSciences
- ADAMA
- VILMORIN & CIE
- Certis Biologicals
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
Related Reports
From
Biotechnology for the Non-Biotechnologist Training Course (December 2, 2024)
- Conference
- 5 Days
- Global
From
From
Agricultural Biotechnology: Emerging Technologies and Global Markets
- Report
- 163 Pages
- Global
From
This product is a market research report. Each license type allows a set number of users to access the report. Please select an option from the list below. This product is a market research report. This is a single user license, allowing one user access to the product. This product is a market research report. This is a single user license, allowing one user access to the product. The product is a PDF. This product is a market research report. This is an enterprise license, allowing all employees within your organization access to the product. The product is a PDF. 
